((Sara M. Tinsley, Ph.D., ARNP, AOCN))
In an IPOP treatment approach, appropriate patients can receive induction in an outpatient setting, followed by a planned admission.
The patient is seen daily for monitoring.
There are a number of team members needed to support an IPOP approach.
A nurse practitioner or physician assistant should be available to see the patient daily.
An attending physician should also be available for any consultations.
A social worker may also play a role in IPOP coordination.
They can help assess the suitability of the patient's transportation, local support system, and anything else that may impact the patient’s participation in IPOP treatment.
VYXEOS is indicated for the treatment of newly-diagnosed therapy-related acute myeloid leukemia (t‑AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.
IMPORTANT SAFETY INFORMATION